SPEC:LSE Inspecs Group plc

GBX 47.50 -1.50 -3.061224
Icon

Inspecs Group plc (SPEC:LSE) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 47.50

-1.50 (-3.06)%

GBX 0.06B

0.47M

N/A

N/A

Icon

SPEC:LSE

Inspecs Group plc (GBX)
COMMON STOCK | LSE
GBX 47.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.06B

N/A

GBX 47.50

Inspecs Group plc (SPEC:LSE) Stock Forecast

N/A

Based on the Inspecs Group plc stock forecast from 0 analysts, the average analyst target price for Inspecs Group plc is not available over the next 12 months. Inspecs Group plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Inspecs Group plc is Slightly Bullish , which is based on 8 positive signals and 5 negative signals. At the last closing, Inspecs Group plc’s stock price was GBX 47.50. Inspecs Group plc’s stock price has changed by -12.04% over the past week, -22.13% over the past month and -51.78% over the last year.

No recent analyst target price found for Inspecs Group plc
No recent average analyst rating found for Inspecs Group plc

Company Overview Inspecs Group plc

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide. It distributes frames and optical products. The company offers its eyewear under the Viktor & Rolf, Valerie, Lyle & Scott, Barbour, Liberty, Henri Lloyd, O'Ne...Read More

https://www.inspecs.com

7-10 Kelso Place, Bath, United Kingdom, BA1 3AU

1,732

December

GBX

UK

Adjusted Closing Price for Inspecs Group plc (SPEC:LSE)

Loading...

Unadjusted Closing Price for Inspecs Group plc (SPEC:LSE)

Loading...

Share Trading Volume for Inspecs Group plc Shares

Loading...

Compare Performance of Inspecs Group plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SPEC:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Inspecs Group plc (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CTEC:LSE
ConvaTec Group PLC -0.40 (-0.14%) GBX5.09B 82.80 15.32

ETFs Containing SPEC

Symbol Name SPEC's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Inspecs Group plc (SPEC:LSE) Stock

Stock Target Advisor's fundamental analysis for Inspecs Group plc's stock is Slightly Bullish .

Unfortunately we do not have enough data on SPEC:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on SPEC:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on SPEC:LSE's stock to indicate if its overvalued.

The last closing price of SPEC:LSE's stock was GBX 47.50.

The most recent market capitalization for SPEC:LSE is GBX 0.06B.

Unfortunately we do not have enough analyst data on SPEC:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Inspecs Group plc's stock.

As per our most recent records Inspecs Group plc has 1,732 Employees.

Inspecs Group plc's registered address is 7-10 Kelso Place, Bath, United Kingdom, BA1 3AU. You can get more information about it from Inspecs Group plc's website at https://www.inspecs.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...